Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Unum Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-17Dec-31-16Dec-31-15
Revenues29.822.06.9
            Revenue growth35.6%221.0% 
Cost of goods sold34.525.49.6
Gross profit-4.7-3.4-2.7
            Gross margin-15.7%-15.6%-39.8%
General and administrative4.73.42.7
EBIT-26.2-19.1-6.6
            EBIT margin-87.7%-86.7%-96.2%
Pre-tax income-25.5-18.1-6.6
Income taxes0.00.00.0
            Tax rate0.0%0.0%0.0%
Net income0.00.00.0
            Net margin-0.1%-0.1%-0.1%
 
Diluted EPS($2.51)($1.78)($0.65)
Shares outstanding (diluted)0.00.00.0
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2018 | Contact Us | Data Disclaimer | Terms of Use | Privacy